Blood‐based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer-Reference-Cited by-同舟云学术

Blood‐based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer

Published:2022-12 Issue:5 Volume:152 Page:1036-1049
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Christensen Troels D.¹^ORCID,Jensen Christina²,Larsen Ole¹,Leerhøy Bonna³,Hansen Carsten P.⁴,Madsen Kasper¹,Høgdall Dan¹,Karsdal Morten A.²,Chen Inna M.¹^ORCID,Nielsen Dorte¹⁵,Johansen Julia S.¹⁵⁶,Willumsen Nicholas²^ORCID

Affiliation:

1. Department of Oncology Copenhagen University Hospital – Herlev and Gentofte Herlev Denmark

2. Biomarkers & Research, Nordic Bioscience A/S Herlev Denmark

3. Digestive Disease Center Copenhagen University Hospital – Bispebjerg and Frederiksberg Copenhagen Denmark

4. Department of Surgery Copenhagen University Hospital – Rigshospitalet Copenhagen Denmark

5. Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

6. Department of Medicine Copenhagen University Hospital – Herlev and Gentofte Herlev Denmark

Funder

Kræftens Bekæmpelse

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34356

Reference50 articles.

1. Biliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013

2. Biliary tract cancer

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

4. Incidence and mortality trends for biliary tract cancers in Austria

5. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration;Frontiers in Pharmacology;2024-09-02

2. The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases;Matrix Biology;2024-09

3. Type XII collagen is elevated in serum from patients with solid tumors: a non-invasive biomarker of activated fibroblasts;Clinical and Experimental Medicine;2024-07-24

4. Type IX Collagen Turnover Is Altered in Patients with Solid Tumors;Cancers;2024-05-27

5. Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease;Endocrine Reviews;2023-12-13